NTV Asset Management LLC lowered its holdings in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 1.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,100 shares of the medical research company’s stock after selling 150 shares during the period. NTV Asset Management LLC’s holdings in Thermo Fisher Scientific were worth $1,413,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of TMO. Proficio Capital Partners LLC boosted its stake in Thermo Fisher Scientific by 71.5% during the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after buying an additional 253 shares in the last quarter. Chicago Partners Investment Group LLC acquired a new stake in shares of Thermo Fisher Scientific in the 2nd quarter valued at $108,000. Cribstone Capital Management LLC boosted its stake in shares of Thermo Fisher Scientific by 8.7% in the 2nd quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 50 shares in the last quarter. Sharkey Howes & Javer boosted its stake in shares of Thermo Fisher Scientific by 1.0% in the 1st quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after purchasing an additional 7 shares in the last quarter. Finally, Shine Investment Advisory Services Inc. acquired a new stake in shares of Thermo Fisher Scientific in the 2nd quarter valued at $113,000. Hedge funds and other institutional investors own 83.36% of the company’s stock.

Thermo Fisher Scientific Inc (TMO) opened at 193.51 on Thursday. The company has a 50 day moving average price of $185.59 and a 200-day moving average price of $173.48. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $194.30. The company has a market capitalization of $75.49 billion, a PE ratio of 33.71 and a beta of 1.05.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.03. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. Thermo Fisher Scientific’s revenue was up 10.2% compared to the same quarter last year. During the same period last year, the firm posted $2.03 earnings per share. On average, analysts anticipate that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be paid a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.31%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.45%.

TMO has been the topic of several recent analyst reports. Deutsche Bank AG set a $200.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Saturday, June 10th. BidaskClub downgraded shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 27th. Citigroup Inc. restated a “buy” rating and issued a $201.00 target price (up previously from $182.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 10th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 target price on the stock in a research note on Tuesday, July 11th. Finally, Wells Fargo & Company restated an “outperform” rating and issued a $200.00 target price (up previously from $195.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 13th. One investment analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $202.21.

COPYRIGHT VIOLATION NOTICE: “NTV Asset Management LLC Sells 150 Shares of Thermo Fisher Scientific Inc (TMO)” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/05/ntv-asset-management-llc-sells-150-shares-of-thermo-fisher-scientific-inc-tmo.html.

In related news, SVP Gregory J. Herrema sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, August 2nd. The stock was sold at an average price of $176.02, for a total value of $5,280,600.00. Following the sale, the senior vice president now directly owns 67,016 shares of the company’s stock, valued at $11,796,156.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jim P. Manzi sold 1,000 shares of the firm’s stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $175.20, for a total value of $175,200.00. Following the completion of the sale, the director now directly owns 38,757 shares in the company, valued at $6,790,226.40. The disclosure for this sale can be found here. Insiders sold 52,738 shares of company stock worth $9,302,112 over the last ninety days. 0.49% of the stock is currently owned by insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.